Note 16. Segment Reporting: Schedule of Segment Reporting Information, by Segment (Tables)

9 Months Ended

Sep. 30, 2016

Tables/Schedules

Schedule of Segment Reporting Information, by Segment

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
		2016		2015		2016		2015
Revenues:
Medical Stop-Loss (A)	$	5,433	$	53,320	$	21,397	$	160,310
Specialty Health		44,684		45,193		126,454		141,356
Group disability, life and DBL		26,196		24,404		77,409		65,879
Individual life, annuities and other (A)		717		7,987		2,053		25,287
Corporate		620		45		2,350		137
		77,650		130,949		229,663		392,969
Gain on sale of subsidiary to joint venture		-		10,161		-		10,161
Net realized investment gains (losses)		2,367		(1,109)		3,945		2,991
Net impairment losses recognized in earnings		(1,475)		(228)		(1,475)		(228)
Total revenues	$	78,542	$	139,773	$	232,133	$	405,893
Income from continuing operations
before income taxes:
Medical Stop-Loss (A)	$	2,176	$	5,218	$	13,926	$	14,176
Specialty Health (B)		1,369		2,399		3,754		5,231
Group disability, life and DBL		5,323		4,400		13,533		10,774
Individual life, annuities and other (A)(C)		(410)		3,623		(1,888)		1,238
Corporate		(1,908)		(2,111)		(7,106)		(5,308)
		6,550		13,529		22,219		26,111
Gain on sale of subsidiary to joint venture		-		10,161		-		10,161
Net realized investment gains (losses)		2,367		(1,109)		3,945		2,991
Net impairment losses recognized in earnings		(1,475)		(228)		(1,475)		(228)
Interest expense		(440)		(444)		(1,366)		(1,354)
Income from continuing operations
before income taxes	$	7,002	$	21,909	$	23,323	$	37,681